ReNeuron rises on research news
Shares in AIM-listed stem cell therapeutics specialist ReNeuron Group rose by 8.03% to 146.92p after it announced the publication of new research data.
Shares in AIM-listed stem cell therapeutics specialist ReNeuron Group rose by 8.03% to 146.92p after it announced the publication of new research data.
Robert Stephens, CFA, discusses why a particular FTSE 100 property company may have a favourable long-term outlook.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
The price of shares in Whitbread rose by 2.17% despite revenues for the half year ended 30th September dropping very slightly relative to last year.
AIM-listed online equipment retailer Gear4Music climbed by 12.10% as total sales rose by 16% due to a strong international performance.
AIM-listed software as a service outfit essensys saw its share price increase by 1.90% after it posted a 26% increase in its annual revenues.
Nick Sudbury explores some of the best ways to invest for retirement using funds and trusts within your pension portfolio.
Since I profiled Capital Drilling in late July it appears that events have been moving at quite a pace, writes Mark Watson-Mitchell.
Mind Gym has seen its share price rise by 8.57% after it said revenues for the six months ended 30th September would be 24% ahead of the comparative period
The price of shares in AIM-listed gold miner Hummingbird Resources rose by 3.76% as production increased and costs fell during the third quarter of 2019.